0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Methylphenidate Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-27R6767
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Methylphenidate Drug Market Insights Forecast to 2028
BUY CHAPTERS

Methylphenidate Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27R6767
Report
September 2024
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Methylphenidate Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Methylphenidate Drug - Market

Methylphenidate Drug - Market

Methylphenidate Drug is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
The global market for Methylphenidate Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Methylphenidate Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Methylphenidate Drug by region & country, by Type, and by Application.
The Methylphenidate Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylphenidate Drug.
Market Segmentation

Scope of Methylphenidate Drug - Market Report

Report Metric Details
Report Name Methylphenidate Drug - Market
CAGR 5%
Segment by Type:
  • Tablet
  • Capsule
Segment by Application
  • Children(6-17 years)
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Janssen Pharmaceuticals, NEOS Therapeutics, Rhodes Pharmaceuticals, Noven Therapeutics, Ironshore Pharmaceuticals, Lannett Company, Novartis, Teva, Tris Pharma, Amneal, Impax Laboratories, Mylan, Trigen Laboratories, Sun Pharmaceutical, Oxford Pharm, Novel Laboratories, Breckenridge Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Methylphenidate Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Methylphenidate Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Methylphenidate Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Methylphenidate Drug - Market report?

Ans: The main players in the Methylphenidate Drug - Market are Janssen Pharmaceuticals, NEOS Therapeutics, Rhodes Pharmaceuticals, Noven Therapeutics, Ironshore Pharmaceuticals, Lannett Company, Novartis, Teva, Tris Pharma, Amneal, Impax Laboratories, Mylan, Trigen Laboratories, Sun Pharmaceutical, Oxford Pharm, Novel Laboratories, Breckenridge Pharmaceutical

What are the Application segmentation covered in the Methylphenidate Drug - Market report?

Ans: The Applications covered in the Methylphenidate Drug - Market report are Children(6-17 years), Adult

What are the Type segmentation covered in the Methylphenidate Drug - Market report?

Ans: The Types covered in the Methylphenidate Drug - Market report are Tablet, Capsule

1 Market Overview
1.1 Methylphenidate Drug Product Introduction
1.2 Global Methylphenidate Drug Market Size Forecast
1.2.1 Global Methylphenidate Drug Sales Value (2019-2030)
1.2.2 Global Methylphenidate Drug Sales Volume (2019-2030)
1.2.3 Global Methylphenidate Drug Sales Price (2019-2030)
1.3 Methylphenidate Drug Market Trends & Drivers
1.3.1 Methylphenidate Drug Industry Trends
1.3.2 Methylphenidate Drug Market Drivers & Opportunity
1.3.3 Methylphenidate Drug Market Challenges
1.3.4 Methylphenidate Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Methylphenidate Drug Players Revenue Ranking (2023)
2.2 Global Methylphenidate Drug Revenue by Company (2019-2024)
2.3 Global Methylphenidate Drug Players Sales Volume Ranking (2023)
2.4 Global Methylphenidate Drug Sales Volume by Company Players (2019-2024)
2.5 Global Methylphenidate Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Methylphenidate Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Methylphenidate Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Methylphenidate Drug
2.9 Methylphenidate Drug Market Competitive Analysis
2.9.1 Methylphenidate Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Methylphenidate Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Capsule
3.2 Global Methylphenidate Drug Sales Value by Type
3.2.1 Global Methylphenidate Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Methylphenidate Drug Sales Value, by Type (2019-2030)
3.2.3 Global Methylphenidate Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Methylphenidate Drug Sales Volume by Type
3.3.1 Global Methylphenidate Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Methylphenidate Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Methylphenidate Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Methylphenidate Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Children(6-17 years)
4.1.2 Adult
4.2 Global Methylphenidate Drug Sales Value by Application
4.2.1 Global Methylphenidate Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Methylphenidate Drug Sales Value, by Application (2019-2030)
4.2.3 Global Methylphenidate Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Methylphenidate Drug Sales Volume by Application
4.3.1 Global Methylphenidate Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Methylphenidate Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Methylphenidate Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Methylphenidate Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Methylphenidate Drug Sales Value by Region
5.1.1 Global Methylphenidate Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Methylphenidate Drug Sales Value by Region (2019-2024)
5.1.3 Global Methylphenidate Drug Sales Value by Region (2025-2030)
5.1.4 Global Methylphenidate Drug Sales Value by Region (%), (2019-2030)
5.2 Global Methylphenidate Drug Sales Volume by Region
5.2.1 Global Methylphenidate Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Methylphenidate Drug Sales Volume by Region (2019-2024)
5.2.3 Global Methylphenidate Drug Sales Volume by Region (2025-2030)
5.2.4 Global Methylphenidate Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Methylphenidate Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Methylphenidate Drug Sales Value, 2019-2030
5.4.2 North America Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Methylphenidate Drug Sales Value, 2019-2030
5.5.2 Europe Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Methylphenidate Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Methylphenidate Drug Sales Value, 2019-2030
5.7.2 South America Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Methylphenidate Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Methylphenidate Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Methylphenidate Drug Sales Value
6.2.1 Key Countries/Regions Methylphenidate Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Methylphenidate Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Methylphenidate Drug Sales Value, 2019-2030
6.3.2 United States Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Methylphenidate Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Methylphenidate Drug Sales Value, 2019-2030
6.4.2 Europe Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Methylphenidate Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Methylphenidate Drug Sales Value, 2019-2030
6.5.2 China Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Methylphenidate Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Methylphenidate Drug Sales Value, 2019-2030
6.6.2 Japan Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Methylphenidate Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Methylphenidate Drug Sales Value, 2019-2030
6.7.2 South Korea Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Methylphenidate Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Methylphenidate Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Methylphenidate Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Methylphenidate Drug Sales Value, 2019-2030
6.9.2 India Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Methylphenidate Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Janssen Pharmaceuticals
7.1.1 Janssen Pharmaceuticals Company Information
7.1.2 Janssen Pharmaceuticals Introduction and Business Overview
7.1.3 Janssen Pharmaceuticals Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Janssen Pharmaceuticals Methylphenidate Drug Product Offerings
7.1.5 Janssen Pharmaceuticals Recent Development
7.2 NEOS Therapeutics
7.2.1 NEOS Therapeutics Company Information
7.2.2 NEOS Therapeutics Introduction and Business Overview
7.2.3 NEOS Therapeutics Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 NEOS Therapeutics Methylphenidate Drug Product Offerings
7.2.5 NEOS Therapeutics Recent Development
7.3 Rhodes Pharmaceuticals
7.3.1 Rhodes Pharmaceuticals Company Information
7.3.2 Rhodes Pharmaceuticals Introduction and Business Overview
7.3.3 Rhodes Pharmaceuticals Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Rhodes Pharmaceuticals Methylphenidate Drug Product Offerings
7.3.5 Rhodes Pharmaceuticals Recent Development
7.4 Noven Therapeutics
7.4.1 Noven Therapeutics Company Information
7.4.2 Noven Therapeutics Introduction and Business Overview
7.4.3 Noven Therapeutics Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Noven Therapeutics Methylphenidate Drug Product Offerings
7.4.5 Noven Therapeutics Recent Development
7.5 Ironshore Pharmaceuticals
7.5.1 Ironshore Pharmaceuticals Company Information
7.5.2 Ironshore Pharmaceuticals Introduction and Business Overview
7.5.3 Ironshore Pharmaceuticals Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ironshore Pharmaceuticals Methylphenidate Drug Product Offerings
7.5.5 Ironshore Pharmaceuticals Recent Development
7.6 Lannett Company
7.6.1 Lannett Company Company Information
7.6.2 Lannett Company Introduction and Business Overview
7.6.3 Lannett Company Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lannett Company Methylphenidate Drug Product Offerings
7.6.5 Lannett Company Recent Development
7.7 Novartis
7.7.1 Novartis Company Information
7.7.2 Novartis Introduction and Business Overview
7.7.3 Novartis Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Novartis Methylphenidate Drug Product Offerings
7.7.5 Novartis Recent Development
7.8 Teva
7.8.1 Teva Company Information
7.8.2 Teva Introduction and Business Overview
7.8.3 Teva Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Teva Methylphenidate Drug Product Offerings
7.8.5 Teva Recent Development
7.9 Tris Pharma
7.9.1 Tris Pharma Company Information
7.9.2 Tris Pharma Introduction and Business Overview
7.9.3 Tris Pharma Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Tris Pharma Methylphenidate Drug Product Offerings
7.9.5 Tris Pharma Recent Development
7.10 Amneal
7.10.1 Amneal Company Information
7.10.2 Amneal Introduction and Business Overview
7.10.3 Amneal Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Amneal Methylphenidate Drug Product Offerings
7.10.5 Amneal Recent Development
7.11 Impax Laboratories
7.11.1 Impax Laboratories Company Information
7.11.2 Impax Laboratories Introduction and Business Overview
7.11.3 Impax Laboratories Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Impax Laboratories Methylphenidate Drug Product Offerings
7.11.5 Impax Laboratories Recent Development
7.12 Mylan
7.12.1 Mylan Company Information
7.12.2 Mylan Introduction and Business Overview
7.12.3 Mylan Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Mylan Methylphenidate Drug Product Offerings
7.12.5 Mylan Recent Development
7.13 Trigen Laboratories
7.13.1 Trigen Laboratories Company Information
7.13.2 Trigen Laboratories Introduction and Business Overview
7.13.3 Trigen Laboratories Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Trigen Laboratories Methylphenidate Drug Product Offerings
7.13.5 Trigen Laboratories Recent Development
7.14 Sun Pharmaceutical
7.14.1 Sun Pharmaceutical Company Information
7.14.2 Sun Pharmaceutical Introduction and Business Overview
7.14.3 Sun Pharmaceutical Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sun Pharmaceutical Methylphenidate Drug Product Offerings
7.14.5 Sun Pharmaceutical Recent Development
7.15 Oxford Pharm
7.15.1 Oxford Pharm Company Information
7.15.2 Oxford Pharm Introduction and Business Overview
7.15.3 Oxford Pharm Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Oxford Pharm Methylphenidate Drug Product Offerings
7.15.5 Oxford Pharm Recent Development
7.16 Novel Laboratories
7.16.1 Novel Laboratories Company Information
7.16.2 Novel Laboratories Introduction and Business Overview
7.16.3 Novel Laboratories Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Novel Laboratories Methylphenidate Drug Product Offerings
7.16.5 Novel Laboratories Recent Development
7.17 Breckenridge Pharmaceutical
7.17.1 Breckenridge Pharmaceutical Company Information
7.17.2 Breckenridge Pharmaceutical Introduction and Business Overview
7.17.3 Breckenridge Pharmaceutical Methylphenidate Drug Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Breckenridge Pharmaceutical Methylphenidate Drug Product Offerings
7.17.5 Breckenridge Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Methylphenidate Drug Industrial Chain
8.2 Methylphenidate Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Methylphenidate Drug Sales Model
8.5.2 Sales Channel
8.5.3 Methylphenidate Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Methylphenidate Drug Market Trends
    Table 2. Methylphenidate Drug Market Drivers & Opportunity
    Table 3. Methylphenidate Drug Market Challenges
    Table 4. Methylphenidate Drug Market Restraints
    Table 5. Global Methylphenidate Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Methylphenidate Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Methylphenidate Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Methylphenidate Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Methylphenidate Drug Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Methylphenidate Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Methylphenidate Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Methylphenidate Drug
    Table 13. Global Methylphenidate Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Methylphenidate Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Methylphenidate Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Methylphenidate Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Methylphenidate Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Methylphenidate Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Methylphenidate Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Methylphenidate Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Methylphenidate Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Methylphenidate Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Methylphenidate Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Methylphenidate Drug Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Methylphenidate Drug Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Methylphenidate Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Methylphenidate Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Methylphenidate Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Methylphenidate Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Methylphenidate Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Methylphenidate Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Methylphenidate Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Methylphenidate Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Methylphenidate Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Methylphenidate Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Methylphenidate Drug Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Methylphenidate Drug Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Methylphenidate Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Methylphenidate Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Methylphenidate Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Methylphenidate Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Methylphenidate Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Methylphenidate Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Methylphenidate Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Methylphenidate Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Methylphenidate Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Methylphenidate Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Methylphenidate Drug Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Methylphenidate Drug Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Methylphenidate Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Methylphenidate Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Methylphenidate Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Methylphenidate Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Methylphenidate Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. Janssen Pharmaceuticals Company Information
    Table 58. Janssen Pharmaceuticals Introduction and Business Overview
    Table 59. Janssen Pharmaceuticals Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Janssen Pharmaceuticals Methylphenidate Drug Product Offerings
    Table 61. Janssen Pharmaceuticals Recent Development
    Table 62. NEOS Therapeutics Company Information
    Table 63. NEOS Therapeutics Introduction and Business Overview
    Table 64. NEOS Therapeutics Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. NEOS Therapeutics Methylphenidate Drug Product Offerings
    Table 66. NEOS Therapeutics Recent Development
    Table 67. Rhodes Pharmaceuticals Company Information
    Table 68. Rhodes Pharmaceuticals Introduction and Business Overview
    Table 69. Rhodes Pharmaceuticals Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Rhodes Pharmaceuticals Methylphenidate Drug Product Offerings
    Table 71. Rhodes Pharmaceuticals Recent Development
    Table 72. Noven Therapeutics Company Information
    Table 73. Noven Therapeutics Introduction and Business Overview
    Table 74. Noven Therapeutics Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Noven Therapeutics Methylphenidate Drug Product Offerings
    Table 76. Noven Therapeutics Recent Development
    Table 77. Ironshore Pharmaceuticals Company Information
    Table 78. Ironshore Pharmaceuticals Introduction and Business Overview
    Table 79. Ironshore Pharmaceuticals Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Ironshore Pharmaceuticals Methylphenidate Drug Product Offerings
    Table 81. Ironshore Pharmaceuticals Recent Development
    Table 82. Lannett Company Company Information
    Table 83. Lannett Company Introduction and Business Overview
    Table 84. Lannett Company Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Lannett Company Methylphenidate Drug Product Offerings
    Table 86. Lannett Company Recent Development
    Table 87. Novartis Company Information
    Table 88. Novartis Introduction and Business Overview
    Table 89. Novartis Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Novartis Methylphenidate Drug Product Offerings
    Table 91. Novartis Recent Development
    Table 92. Teva Company Information
    Table 93. Teva Introduction and Business Overview
    Table 94. Teva Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Teva Methylphenidate Drug Product Offerings
    Table 96. Teva Recent Development
    Table 97. Tris Pharma Company Information
    Table 98. Tris Pharma Introduction and Business Overview
    Table 99. Tris Pharma Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Tris Pharma Methylphenidate Drug Product Offerings
    Table 101. Tris Pharma Recent Development
    Table 102. Amneal Company Information
    Table 103. Amneal Introduction and Business Overview
    Table 104. Amneal Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Amneal Methylphenidate Drug Product Offerings
    Table 106. Amneal Recent Development
    Table 107. Impax Laboratories Company Information
    Table 108. Impax Laboratories Introduction and Business Overview
    Table 109. Impax Laboratories Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Impax Laboratories Methylphenidate Drug Product Offerings
    Table 111. Impax Laboratories Recent Development
    Table 112. Mylan Company Information
    Table 113. Mylan Introduction and Business Overview
    Table 114. Mylan Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Mylan Methylphenidate Drug Product Offerings
    Table 116. Mylan Recent Development
    Table 117. Trigen Laboratories Company Information
    Table 118. Trigen Laboratories Introduction and Business Overview
    Table 119. Trigen Laboratories Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Trigen Laboratories Methylphenidate Drug Product Offerings
    Table 121. Trigen Laboratories Recent Development
    Table 122. Sun Pharmaceutical Company Information
    Table 123. Sun Pharmaceutical Introduction and Business Overview
    Table 124. Sun Pharmaceutical Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Sun Pharmaceutical Methylphenidate Drug Product Offerings
    Table 126. Sun Pharmaceutical Recent Development
    Table 127. Oxford Pharm Company Information
    Table 128. Oxford Pharm Introduction and Business Overview
    Table 129. Oxford Pharm Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Oxford Pharm Methylphenidate Drug Product Offerings
    Table 131. Oxford Pharm Recent Development
    Table 132. Novel Laboratories Company Information
    Table 133. Novel Laboratories Introduction and Business Overview
    Table 134. Novel Laboratories Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Novel Laboratories Methylphenidate Drug Product Offerings
    Table 136. Novel Laboratories Recent Development
    Table 137. Breckenridge Pharmaceutical Company Information
    Table 138. Breckenridge Pharmaceutical Introduction and Business Overview
    Table 139. Breckenridge Pharmaceutical Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Breckenridge Pharmaceutical Methylphenidate Drug Product Offerings
    Table 141. Breckenridge Pharmaceutical Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Methylphenidate Drug Downstream Customers
    Table 145. Methylphenidate Drug Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Methylphenidate Drug Product Picture
    Figure 2. Global Methylphenidate Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Methylphenidate Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Methylphenidate Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Methylphenidate Drug Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Methylphenidate Drug Report Years Considered
    Figure 7. Global Methylphenidate Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Methylphenidate Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Methylphenidate Drug Revenue in 2023
    Figure 10. Methylphenidate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tablet Picture
    Figure 12. Capsule Picture
    Figure 13. Global Methylphenidate Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Methylphenidate Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Methylphenidate Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Methylphenidate Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Methylphenidate Drug Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Children(6-17 years)
    Figure 19. Product Picture of Adult
    Figure 20. Global Methylphenidate Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Methylphenidate Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Methylphenidate Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Methylphenidate Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Methylphenidate Drug Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Methylphenidate Drug Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Methylphenidate Drug Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Methylphenidate Drug Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Methylphenidate Drug Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Methylphenidate Drug Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Methylphenidate Drug Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Methylphenidate Drug Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Methylphenidate Drug Sales Volume (%), (2019-2030)
    Figure 37. United States Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Methylphenidate Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Methylphenidate Drug Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Methylphenidate Drug Sales Value by Application (%), 2023 VS 2030
    Figure 58. Methylphenidate Drug Industrial Chain
    Figure 59. Methylphenidate Drug Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS